| NDC Code | 68083-412-10 |
|---|
| Package Description | 10 VIAL, SINGLE-DOSE in 1 CARTON (68083-412-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 68083-412 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Cangrelor |
|---|
| Non-Proprietary Name | Cangrelor |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20250811 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA213551 |
|---|
| Manufacturer | Gland Pharma Limited |
|---|
| Substance Name | CANGRELOR |
|---|
| Strength | 50 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA] |
|---|